会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • MULTI-COMPONENT VACCINE TO PROTECT AGAINST DISEASE CAUSED BY <i>HAEMOPHILUS INFLUENZAE</i> AND <i>MORAXELLA CATARRHALIS</i>
    • 多元分子疫苗可以防止由海马流感引起的疾病和 MORAXELLA CATARRHALIS
    • WO0105424A3
    • 2001-08-02
    • PCT/CA0000811
    • 2000-07-11
    • CONNAUGHT LABLOOSMORE SHEENA MYANG YAN PINGKLEIN MICHEL HSASAKI KEN
    • LOOSMORE SHEENA MYANG YAN-PINGKLEIN MICHEL HSASAKI KEN
    • A61K39/116A61P31/04
    • A61K39/102A61K39/1045A61K2039/55505A61K2039/70
    • A multi-valent immunogenic composition confers protection on an immunized host against infection caused by both Haemophilus influenzae and Moraxella catarrhalis . Such composition comprises at least four antigens comprising at least one antigen from Haemophilus influenzae , and at least one antigen from Moraxella catarrhalis . Three of the antigens are adhesins. High molecular weight (HMW) proteins and Haemophilus influenzae adhesin (Hia) proteins of non-typeable Haemophilus and a 200 kDa outer membrane protein of Moraxella catarrhalis comprise the adhesin components while the other antigen is a non-proteolytic analog of Hin47 protein. Each component does not impair the immunogenicity of the others. The multi-valent immunogenic composition may be combined with DTP component vaccines, which may also include non-virulent poliovirus and PRP-T, to provide a component vaccine without impairment of the immunogenic properties of the other antigens.
    • 多价免疫原性组合物赋予免疫宿主免受针对流感嗜血杆菌和卡他莫拉菌的<! - SIPO - >引起的感染的保护。 这样的组合物包含至少四种包含来自嗜血杆菌流感嗜血杆菌的至少一种抗原的抗原和至少一种来自卡他莫拉菌的抗原。 三种抗原是粘附素。 不可分泌的嗜血杆菌的高分子量(HMW)蛋白和流感嗜血杆菌粘附素(Hia)蛋白和卡他莫拉菌的200kDa外膜蛋白包含粘附素组分,而另一种抗原是Hin47蛋白的非蛋白水解类似物。 每个成分不影响其他成分的免疫原性。 多价免疫原性组合物可以与DTP组分疫苗组合,其也可以包括非毒性脊髓灰质炎病毒和PRP-T,以提供组分疫苗,而不损害其他抗原的免疫原性。